MoonLake Immunotherapeuti... (MLTX)
45.77
-0.73 (-1.57%)
At close: Jan 15, 2025, 12:51 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -44.08M | -64.51M | -53.64M | -90.84K |
| Depreciation & Amortization | 13.16K | 12.36K | 4.97K | n/a |
| Stock-Based Compensation | 7.11M | 9.65K | 10.86K | n/a |
| Other Working Capital | -6.22M | -44.80K | 3.06M | -215.94K |
| Other Non-Cash Items | 399.51K | 372.49K | 12.57M | -9.92K |
| Deferred Income Tax | n/a | n/a | 1.40M | n/a |
| Change in Working Capital | -6.22M | -1.43M | 4.48M | -215.94K |
| Operating Cash Flow | -42.78M | -55.89M | -35.18M | -316.69K |
| Capital Expenditures | -284.63K | -16.01K | -50.71K | n/a |
| Acquisitions | n/a | 32.32K | n/a | n/a |
| Purchase of Investments | -175.73M | -42.23M | n/a | -115.00M |
| Sales Maturities Of Investments | 150.83M | 9.90M | n/a | n/a |
| Other Investing Acitivies | n/a | -32.32K | n/a | n/a |
| Investing Cash Flow | -25.18M | -32.34M | -50.71K | -115.00M |
| Debt Repayment | n/a | -15.00M | 15.00M | n/a |
| Common Stock Repurchased | n/a | n/a | -6.20K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.75M | 134.69M | n/a | -347.38K |
| Financial Cash Flow | 479.70M | 119.69M | 43.26M | 116.65M |
| Net Cash Flow | 411.66M | 31.47M | 6.70M | 1.34M |
| Free Cash Flow | -43.06M | -55.91M | -35.23M | -316.69K |